Publications by authors named "Erling Chen"

Claim this Profile
O
Optimizing Timing and Preparation for Allogeneic Hematopoietic Stem Cell Transplantation in Higher-Risk Myelodysplastic Syndromes.
Liangquan Geng, Erling Chen, Yanping Ji, Huilan Liu, Zimin Sun

Blood Lymphat Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative-Donor Transplants in Adults ≤ 55 Years Old With Haematological Cancers: Young Versus Older Related HLA-Haplotype-Mismatched Donor Versus Unrelated Umbilical Cord Blood.
Yu Hu, Sichang Liu, Wangsong Zhai, Saibing Qi, Wei Zhang, Erling Chen, Junren Chen

Clin Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome.
Mengya Lv, Xing Hu, Lijun Zhu, Hui Xu, Erling Chen, Changcheng Zheng

Vasc Health Risk Manag· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successfully treatment of PLZF-RARα positive acute promyelocytic leukemia by Venetoclax combining with decitabine: a case report and literature review.
Ziwei Zhou, Erling Chen, Jiqian Jiang, Lei Xue, Lijun Zhu, Changcheng Zheng

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New criteria for estimating numbers of CD34-positive cells in a graft needed for posttransplant bone marrow recovery.
Yahui Feng, Saibing Qi, Yu Hu, Wen Yan, Yanping Ji, Mengyun Chen, Erling Chen, Junren Chen

Leukemia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and infection risk factors in elderly acute myeloid leukemia patients undergoing induction therapy with venetoclax combined with hypomethylating agents.
Wenshan Zhu, Lijun Zhu, Xing Hu, Erling Chen, Lei Xue, Changcheng Zheng

Am J Cancer Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.
Dan Liu, Juan Tong, Erling Chen, Li Wang, Lei Xue, Changcheng Zheng

Blood Lymphat Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma.
Jinbing Huang, Wensheng Xu, Qiaoqiao Huang, Erling Chen, Junying Chen

Heliyon· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes.
Jiqian Jiang, Yan Wang, Dan Liu, Xiaoyu Wang, Yingqiao Zhu, Erling Chen, Changcheng Zheng

Immunotargets Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study.
Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Changcheng Zheng

Medicina (Kaunas)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine monotherapy is superior to standard-dose cytarabine- based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.
Xiaoyu Wang, Dan Liu, Erling Chen, Li Wang, Na Zhao, Changcheng Zheng

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells.
Junying Chen, Jinbing Huang, Qiaoqiao Huang, Ji Li, Erling Chen

Bioengineered· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis